Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 49-60 of 1784 results.
"Over the study period, IO use increased and generated substantially higher device costs. In the absence of proven clinical superiority, an IV-first strategy with selective IO use appears economically preferable" Marouk et al (2026).
"Gravity-driven and pump-assisted infusion methods differ in dilution and flow dynamics, which directly affect the extravasated dose. This study aimed to extend and validate an analytical model for quantitative comparison of extravasation-related dosimetric risks between both strategies and to inform clinical protocol optimization" Lienhardt et al (2026).
"As previously, these updated GPRs for OPAT in adults and children will support delivery of safe and effective OPAT by providing a set of quality indicators for OPAT in the UK regardless of the setting or service model" Noble et al (2026).
"This case underscores the potential severity of cutaneous complications resulting from GBCA extravasation, especially in high-risk patients with chemotherapy-induced vascular vulnerability or diminished tissue integrity" Zhang et al (2026).
"The NeoKissEs surveillance data show a high level of BSI, a downwards time trend and wide variation among NICUs in both BSI/CLABSI incidence and the extent of use of recommended IP practices" Pijoan et al (2026).
"GPT-5.1 Thinking shows potential to support infection surveillance under strict constraints but exhibits systematic limitations, including overreliance on clinical intuition and difficulty with complex exclusion pathways" Alzyood et al (2026).
A new publication on Hydrodynamic behaviour of anti-reflux needle-free connectors during microinfusion with syringe pump: A bench-top study from the Journal of Vascular Access Hydrodynamic…
"Residual syringe air and infusion pump vertical position are critical, interacting factors that disrupt flow continuity during vasoactive drug delivery" Chang et al (2026).
"HAI prevalence remained stable over six years. However, device utilization increased during 2020-2021, with corresponding rises in device-associated infection rates, particularly VAP" Lara et al (2026).
"Recent large-scale clinical studies of CLABSI diagnosis, treatment, and prevention, alongside evolving antibiotic resistance patterns and new antimicrobial developments, have necessitated updates to clinical management strategies. Consequently, the Chinese Society of Critical Care Medicine (CSCCM) has updated the 2007 guideline on intravascular catheter-related infections" Guideline working group of Chinese Society of Critical Care et al (2026).
"The findings of this review revealed that the oral health conditions of ICU patients can leave patients vulnerable to HAIs, including VAP, NVAP, CLABSI, and AOM. Integrating oral hygiene interventions into routine care for ICU patients could be an effective approach to HAI prevention" Javier et al (2026).
"Newly approved intravenous therapies for Duchenne muscular dystrophy (DMD) have led to unique challenges. Totally implantable venous access ports can be utilized to provide stable intravascular access but can be associated with procedural complications and long-term issues" Batley et al (2026).
